日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B-cell lymphoma

复发/难治性弥漫性大B细胞淋巴瘤CAR-T细胞疗法疗效的微生物组和代谢物生物标志物

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2025016858
Yoon, Sang Eun; Kang, Woorim; Cho, Junhun; Cho, Hyeon Ji; Chalita, Mauricio; Oh, Hyun-Seok; Hyun, Dong-Wook; Han, Sujeong; Kim, Hyun; Sung, Hojun; Lee, Jae-Yun; Park, Bon; Ryu, Kyung Ju; Kim, Hyun-Young; Cho, Duck; Kim, Won Seog; Kim, Seok Jin
B细胞
T细胞
淋巴瘤
代谢
微生物学
T细胞
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

International Consensus Guidelines for Diagnostic Criteria and Checklist for Future Studies for Minimally Invasive Carcinoma ex Pleomorphic Adenoma: An HN CLEAR Initiative

微浸润性多形性腺瘤癌诊断标准及未来研究清单国际共识指南：HN CLEAR倡议

期刊:Head & Neck Pathology
影响因子:4.1
doi:10.1007/s12105-026-01898-z
Beadle, Beth M; Benzerdjeb, Nazim; Cho, Junhun; Costes-Martineau, Valérie; Faquin, William C; Gomez, Ricardo Santiago; Gupta, Ruta; Kholová, Ivana; Nagao, Toshitaka; Rane, Swapnil U; Rito, Miguel; Thompson, Lester D R; Samra, Spinder; Luk, Peter P; Chiosea, Simion I
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Identification of a neoplastic Tfh-like cellular subset in a mouse model of angioimmunoblastic T cell lymphoma

在血管免疫母细胞性T细胞淋巴瘤小鼠模型中鉴定出一种肿瘤性Tfh样细胞亚群

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2026.1715613
Mohammaei, Saba; Lee, Jiyeon; Bouchard, Antoine; Bernal Ballesteros, Evany; Diamantopoulos, Nikoletta; Hou, Lifei; Remold, Eileen; Cho, Junhun; Suh, Woong-Kyung
肿瘤
T细胞
肿瘤免疫
淋巴瘤
T细胞
Tfh
细胞生物学
免疫/内分泌
发表日期：2026
文献求助 收藏

Real-world use of polatuzumab vedotin combined with bendamustine and rituximab for patients with relapsed or refractory large B-cell lymphoma

在复发或难治性大B细胞淋巴瘤患者中，polatuzumab vedotin联合苯达莫司汀和利妥昔单抗的真实世界应用

期刊:Korean Journal of Internal Medicine
影响因子:2.4
doi:10.3904/kjim.2025.282
Kim, Changgon; Yoon, Sang Eun; Kim, Hyun-Young; Cho, Duck; Cho, Junhun; Kim, Won Seog; Kim, Seok Jin
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2026
文献求助 收藏

MiR-340-5p regulates PD-L1 and predicts pembrolizumab response in extranodal NK/T-cell lymphoma

miR-340-5p 调控 PD-L1 并预测结外 NK/T 细胞淋巴瘤对帕博利珠单抗的反应

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-90542-x
Ryu, Kyung Ju; Ji, Haein; Park, Bon; Yoon, Sang Eun; Cho, Junhun; Kim, Won Seog; Kim, Hyeon Ho; Kim, Seok Jin
T细胞
信号转导
淋巴瘤
PD-L1
细胞生物学
发表日期：2025
文献求助 收藏

Clinical Impact of Microbiome Characteristics in Treatment-Naïve Extranodal NK/T-Cell Lymphoma Patients

微生物组特征对初治结外NK/T细胞淋巴瘤患者的临床影响

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2024.675
Yoon, Sang Eun; Kang, Woorim; Cho, Junhun; Chalita, Mauricio; Lee, Je Hee; Hyun, Dong-Wook; Kim, Hyun; Kim, Seok Jin; Kim, Won Seog
T细胞
淋巴瘤
微生物学
T细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

AI-Based Prediction of Bone Conduction Thresholds Using Air Conduction Audiometry Data

基于气导听力测试数据的AI骨导阈值预测

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14186549
Yoon, Chul Young; Lee, Junhun; Kim, Jiwon; You, Sunghwa; Kwak, Chanbeom; Seo, Young Joon
发表日期：2025
文献求助 收藏

Prognostic Significance of Isolated Low-Frequency Hearing Loss: A Longitudinal Audiometric Study

孤立性低频听力损失的预后意义：一项纵向听力学研究

期刊:Journal of Clinical Medicine
影响因子:2.9
doi:10.3390/jcm14196749
Lee, Junhun; Yoon, Chul Young; Kim, Jiwon; Seo, Young Joon
发表日期：2025
文献求助 收藏

Aggressive natural killer cell leukemia therapy in the L-asparaginase era: why are we failing?

L-天冬酰胺酶时代，积极的自然杀伤细胞白血病疗法：为什么我们失败了？

期刊:Blood Research
影响因子:2.8
doi:10.1007/s44313-025-00104-3
Yoon, Sang Eun; Cho, Junhun; Kim, Hyun-Young; Kim, Seok Jin; Kim, Won Seog
白血病
细胞生物学
自然杀伤细胞
发表日期：2025
文献求助 收藏

Clinical outcomes of tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma: insights from a single-center study

tisagenlecleucel治疗复发/难治性弥漫性大B细胞淋巴瘤的临床结果：一项单中心研究的启示

期刊:International Journal of Hematology
影响因子:1.8
doi:10.1007/s12185-025-04006-z
Yoon, Sang Eun; Cho, Junhun; Cho, Duck; Kang, Eun-Sook; Kim, Seok Jin; Kim, Won Seog
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2025
文献求助 收藏